Scilex signs term sheet for $100 million investment from Kazakhstan's iHolding Group
The binding term sheet, disclosed July 6, 2026, contemplates iHolding purchasing newly issued Scilex shares at $15.00 each, subject to due diligence and stockholder approval.
Scilex Holding Company announced on July 6, 2026 that it had signed a binding term sheet with iHolding Group LLP, a private investment group headquartered in Almaty, Republic of Kazakhstan.1 The agreement was entered into on July 3, 2026, according to the company's 8-K filing.
The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Scilex common stock, at a purchase price expected to be $15.00 per share, representing approximately 6,666,667 shares.1
Scilex said the proposed investment would be used to support its continued strategic growth, including expansion of its healthcare and medical technology initiatives, product development and commercialization, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, and other general corporate purposes.1
The deal is not final. The proposed investment remains subject to completion of customary due diligence, the parties' negotiation and execution of definitive agreements, board approvals, and other customary closing conditions, including receipt of the approval of Scilex's stockholders and any required regulatory approvals.1
The filing cautions that there can be no assurance the definitive agreements will be entered into or that the investment will be consummated on the terms described or at all, since the transaction is subject to numerous factors outside the company's control, including market conditions, regulatory approvals, and the actions of third parties.1
Separately, in a prior 8-K, Scilex disclosed a June 24, 2026 term sheet with Datavault AI Inc. under which it expects to purchase 837 BTC held by Datavault for $50 million, with an initial payment of $30 million and the remaining $20 million payable in quarterly installments from the fourth quarter of 2026 through December 31, 2028.2
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.